SCHEDULE 13D/A 0001104659-22-118707 0001301912 XXXXXXXX LIVE 8 American Depositary Shares, each representing 2,000 shares of Common Stock without par value 09/24/2025 false 0001047716 51817R205 LATAM Airlines Group S.A.

Presidente Riesco 5711, 20th Floor Las Condes Santiago F3 999999999

Lewis Schwartz (203) 618-3500 Strategic Value Partners, LLC 100 West Putnam Avenue Greenwich CT 06830 Louis Rambo (202) 416-6800 Proskauer Rose, LLP 1001 Pennsylvania Avenue NW, Suite 600 Washington DC 20004-2533 0001301912 N Strategic Value Partners, LLC OO N DE 0 0 0 0 0 N 0 OO Y Ashton Gate S.a.r.l. OO N N4 0 0 0 0 0 N 0 OO 0001919793 N SVP Special Situations V LLC OO N DE 0 0 0 0 0 N 0 OO Y Wild Heath S.a.r.l. OO N N4 0 0 0 0 0 N 0 OO 0001614275 N SVP Special Situations III-A LLC OO N DE 0 0 0 0 0 N 0 OO Y Grouse Moor S.a.r.l. OO N N4 0 0 0 0 0 N 0 OO 0001726861 N SVP Special Situations IV LLC OO N DE 0 0 0 0 0 N 0 OO Y Meadow Garden S.a.r.l. OO N N4 0 0 0 0 0 N 0 OO Y Green Pasture S.a.r.l. OO N N4 0 0 0 0 0 N 0 OO 0001817732 N SVP Capital Solutions LLC OO N DE 0 0 0 0 0 N 0 OO Y Strategic Value New Rising Fund, L.P. OO N DE 0 0 0 0 0 N 0 PN Y SVP New Rising Management LLC OO N DE 0 0 0 0 0 N 0 OO 0001473996 N Victor Khosla OO N X1 0 0 0 0 0 N 0 OO American Depositary Shares, each representing 2,000 shares of Common Stock without par value LATAM Airlines Group S.A. Presidente Riesco 5711, 20th Floor Las Condes Santiago F3 999999999 Item 4 of the Schedule 13D is amended and supplemented as follows: On September 24, 2025, the Funds entered into an Underwriting Agreement with J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC (the "Underwriters") and the Issuer. Pursuant to the Underwriting Agreement, the Funds sold to the Underwriters 15,503,784 ADSs, each representing 2,000 shares of Common Stock, at a price per ADS of $43.4126 (the "Underwritten Offering"). The ADS purchased by the Underwriters were issued by JPMorgan Chase Bank, N.A. (the "Depositary") and are evidenced by American Depositary Receipts ("ADRs") pursuant to the Deposit Agreement, dated as of September 21, 2017, as amended by the first amendment, dated as of March 12, 2021, and the second amendment, dated as of July 24, 2024 (the "Deposit Agreement"), among the Issuer, the Depositary, and all holders from time to time of the ADRs issued thereunder evidencing ADS representing deposited shares of Common Stock. The Underwritten Offering was effected pursuant to an automatic shelf registration statement on Form F-3 (File No. 333-280866) filed by the Issuer on July 18, 2024. The Underwritten Offering is scheduled to close on September 26, 2025. In accordance with the Underwriting Agreement, the Funds agreed with the Underwriters that, subject to certain exceptions, they may not, during period beginning on September 24, 2025 and continuing to and including the date that is 30 days after the date of the final prospectus related to the Underwriting Agreement, (i) offer, sell, contract to sell, pledge, grant any option, right or warrant to purchase, purchase any option or contract to sell, lend or otherwise transfer or dispose of any shares of Common Stock or ADS, or any options or warrants to purchase any shares of Common Stock or ADS, or any securities convertible into, exchangeable for or that represent the right to receive shares of Common Stock or ADS (such shares of Common Stock, ADS, options, rights, warrants or other securities, collectively, the "Lock-Up Securities"), (ii) engage in any hedging or other transaction or arrangement which is designed to or which reasonably could be expected to lead to or result in a sale, loan, pledge or other disposition, or transfer of any of the economic consequences of ownership, in whole or in part, directly or indirectly, of any Lock-Up Securities, whether any such transaction or arrangement would be settled by delivery of Common Stock, ADS or other securities, in cash or otherwise, (iii) make any demand for or exercise any right with respect to the registration of any Lock-Up Securities or (iv) otherwise publicly announce any intention to engage in or cause any action, activity, transaction or arrangement described in clauses (i), (ii) or (iii) above. Item 5 of the Schedule 13D is amended and supplemented as follows: Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference. Items 7 through 10 of the cover pages to this Schedule 13D are incorporated herein by reference. On September 24, 2025, the Reporting Persons sold (i) an aggregate of 15,503,784 ADSs representing 31,007,568,000 shares of Common Stock in an underwritten offering at a price of $43.4126 per ADS, and (ii) an aggregate of 8,002 shares of Common Stock in the open market at a price of $43.4126 per share. On September 24, 2025, as a result of the transactions reported in Item 5(c) hereof, the Reporting Persons ceased to be beneficial owners of more than five percent of the Common Stock. The disclosure set forth above in Item 4 of this Amendment No. 8 to Schedule 13D is incorporated by reference into this Item 6. Strategic Value Partners, LLC /s/ Lewis Schwartz 09/26/2025 Ashton Gate S.a.r.l. /s/ Lewis Schwartz 09/26/2025 SVP Special Situations V LLC /s/ Lewis Schwartz 09/26/2025 Wild Heath S.a.r.l. /s/ Lewis Schwartz 09/26/2025 SVP Special Situations III-A LLC /s/ Lewis Schwartz 09/26/2025 Grouse Moor S.a.r.l. /s/ Lewis Schwartz 09/26/2025 SVP Special Situations IV LLC /s/ Lewis Schwartz 09/26/2025 Meadow Garden S.a.r.l. /s/ Lewis Schwartz 09/26/2025 Green Pasture S.a.r.l. /s/ Lewis Schwartz 09/26/2025 SVP Capital Solutions LLC /s/ Lewis Schwartz 09/26/2025 Strategic Value New Rising Fund, L.P. /s/ Lewis Schwartz 09/26/2025 SVP New Rising Management LLC /s/ Lewis Schwartz 09/26/2025 Victor Khosla /s/ Victor Khlosa 09/26/2025